Airsculpt Technologies, Inc.
Close on Oct 19, 2026
- Market cap
- $88.13M
- P/E (TTM)
- –
- Dividend yield
- –
About Airsculpt Technologies
Services-Offices & Clinics of Doctors of Medicine, SIC 8011
AirSculpt Technologies, Inc. provides proprietary body contouring and fat removal procedures. The company specializes in minimally invasive aesthetic treatments, including fat extraction, autologous fat transfer, skin tightening, and cellulite reduction. Its proprietary offerings feature specialized fat transfer techniques to enhance areas such as the breasts, buttocks, and hips without foreign implants, alongside targeted radiofrequency and plasma skin laxity treatments. AirSculpt delivers its clinical services through affiliated professional medical associations that employ licensed cosmetic and plastic surgeons, serving individual self-pay consumer patients who seek cosmetic enhancement.
The company operates a network of 31 body contouring centers located across 20 U.S. states and Canada. Facilities are situated in affluent metropolitan and suburban commercial areas. The provided text does not state the location of the company's corporate headquarters.
Summary of the business section of Airsculpt Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Airsculpt Technologies, Inc.
- Founded
- 2012
- Headquarters
- Tampa, FL
- Address
- 2023 West Platt Street 33605
- Phone
- (786) 709-9690
- Employees
- 330, Dec 31, 2025
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- Fiscal year ends
- December 31
- Auditor
- GRANT THORNTON LLP, Tampa, Florida
Stock & identifiers
- Ticker
- AIRS
- Exchange
- Nasdaq
- IPO date
- Oct 29, 2021
- Shares outstanding
- 72M, Aug 7, 2026
- Public float
- $79.80M, Jun 30, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1870940
- CUSIP
- 009496100
- ISIN
- US0094961002
- EIN
- 87-1471855
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Yogesh Jashnani | Chief Executive Officer, Director | 696,475 |
| Aaron Rollins | Executive Chairman, Director | 15,146,039 |
| Michael J. Arthur | Chief Financial Officer | 215,086 |
| Brent R. Wadman | GENERAL COUNSEL | 55,272 |
| Philip Bodie | Chief Accounting Officer | 76,052 |
| Dennis Dean | Chief Financial Officer | 660,668 |
| Adam T. Feinstein | Director | 30,324,180 |
| Caroline Chu | Director | 277,066 |
| Kenneth Higgins | Director | 274,066 |
| Thomas J. Aaron | Director | 276,866 |
| Michael Thomas Doyle | Director | 375,934 |
Employees
Headcount reported in annual reports
“As of December 31, 2025, we employed approximately 330 full-time employees and approximately 33 part-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Mar 16, 2026 | Late filing | Notification of late filing |
| Oct 29, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Oct 27, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |